✦ LIBER ✦

Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study

✍ Scribed by Nikolaos Katirtzoglou; Ioannis Gkiozos; Nektaria Makrilia; Emilia Tsaroucha; Aggeliki Rapti; Grigorios Stratakos; Georgios Fountzilas; Konstantinos N. Syrigos

Book ID: 119935636
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 349 KB
Volume: 11
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2010.n.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of pemetrexed and carbopl

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

✍ Ceresoli, G L; Zucali, P A; Mencoboni, M; Botta, M; Grossi, F; Cortinovis, D; Zi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 265 KB

Pemetrexed plus carboplatin in elderly p

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

✍ Bearz, A; Castagneto, B; Zucali, P A; Favaretto, A; Mencoboni, M; Grossi, F; Cor 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

P-428 A phase II study of pemetrexed and

P-428 A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)

✍ Soto Parra, H.; Zucali, P.; Favaretto, A.; Grossi, F.; Fusi, A.; Marangolo, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Gemcitabine combined with carboplatin in

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study

✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.

Gemcitabine and vinorelbine as second-li

Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy

✍ Toyokawa, Gouji; Takenoyama, Mitsuhiro; Hirai, Fumihiko; Toyozawa, Ryo; Inamasu, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 194 KB

Phase II study of ALIMTA (pemetrexed dis

Phase II study of ALIMTA (pemetrexed disodium, MTA) single agent in patients with malignant pleural mesothelioma

✍ G. Scagliotti; D. Shin; H. Kindler; D. Johnson; U. Keppler 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 363 KB